Kalleid的动态

With 17 years' of experience, 10 FDA and 230+ customer audits, Sannova drives life-saving drug development. Our tailored services suit every need. Partner with us for expert bioanalytical and pharmaceutical support. What sets us apart: ?? Transparent communication ?? Flexible, tailored services We’re just a phone call away. #AnalyticalCROServices #Pharma #BioanalyticalServices #DrugDevelopment #CustomMethodDevelopment

?? Join this FREE webinar to discover how #zenon tackles #dataintegrity challenges in the #pharmaceutical sector, ensuring your data remains complete, accurate, and secure. This event is for anyone keen on #automationsoftware for #reporting and archiving features in pharmaceutical production. Ask our experts questions and stay compliant! ???Register now here. https://hubs.ly/Q02l9v4W0 #DataIntegrity?#PharmaAutomation?#Webinar

''Investigational analysis is all about solving problems.'' Watch our latest video with Shimadzu UK Limited, where our Director of Analytical Science and Digital Transformation, Dr Sam Whitmarsh, discusses the importance of deploying a broad range of testing coupled with deep CMC understanding to solve any of our customers' complex analytical challenges with speed and agility. Visit our Analytical Science webpage to find out more: https://lnkd.in/eCQHDcrQ #ExcellenceInMedicinesDevelopment #AnalyticalScience #ChooseCatSci #GMP #Analytical #InvestigationalAnalysis

Navigating the Complex World of Biopharma Regulations At Lumis International GmbH, we ensure biopharmaceutical products meet safety, efficacy and quality standards. Our expert team, with decades of experience in EU and UK regulations, provides comprehensive regulatory and consulting services for startups and mid-size pharmaceutical companies. We help optimize development, reduce regulatory costs and expedite approvals, ensuring swift patient access to medicinal products. With over 10 years of experience, Lumis is a trusted partner in the biopharma industry, dedicated to excellent customer service and expert guidance. Contact Liam Spencer today to learn how we can support your regulatory needs! #Biopharma #RegulatoryBiopharma #LumisInternational #Biotech #Pharmaceuticals #MedicinalProducts

Navigating the Complex World of Biopharma Regulations At Lumis International GmbH, we ensure biopharmaceutical products meet safety, efficacy and quality standards. Our expert team, with decades of experience in EU and UK regulations, provides comprehensive regulatory and consulting services for startups and mid-size pharmaceutical companies. We help optimize development, reduce regulatory costs and expedite approvals, ensuring swift patient access to medicinal products. With over 10 years of experience, Lumis is a trusted partner in the biopharma industry, dedicated to excellent customer service and expert guidance. Contact Liam Spencer today to learn how we can support your regulatory needs! #Biopharma #RegulatoryBiopharma #LumisInternational #Biotech #Pharmaceuticals #MedicinalProducts

Explore the significant costs associated with failed drug and device launches, and the impact on pharmaceutical companies, in our upcoming webinar with @FiercePharma on April 9, 10am ET. Learn how to navigate challenges from early R&D through to commercialization, avoiding common pitfalls and maximizing the potential for success. Register here to attend the webinar or access the recording, here: https://lnkd.in/diQ934Zd #regulatory #clinicaltrials #drugdiscovery

Read now: https://ow.ly/vo0g50SkgOE Pharmaceutical manufacturers must be informed about the risks and opportunities associated with the FDA guidance on scientific information on unapproved uses (SIUU), especially when launching independently. In this article, our experts help distill the draft guidance into top-level considerations to help companies understand its potential implications and prepare commercialization strategies that balance business impact with scientific integrity, compliance and patient well-being.

Great insights from Allen Koester, Will Knapp, and our Toronto-based Anderson Kong on the complexities and opportunities of decarbonizing pharmaceutical manufacturing facilities. ?? The pharmaceutical industry faces unique sustainability challenges, and this article offers actionable strategies for facilities to achieve a greener future without compromising compliance or operational integrity. Well worth the read! #EngineeredForImpact

What can pharmaceutical manufacturers do to reduce carbon emissions while maintaining operational efficiency? Allen Koester, Will Knapp, and Anderson Kong examine key challenges to decarbonization as well as innovative engineering strategies pharmaceutical industry leaders are implementing to meet operational and sustainability goals.?

Launching new pharmaceutical products efficiently requires navigating complex regulatory hurdles. Our white paper explores the concept of Submission Excellence, a strategic approach to regulatory submissions that empowers life science organizations to overcome launch challenges. Gain valuable insights into best practices and emerging trends to optimize your regulatory strategies and expedite market access. Know more, download https://lnkd.in/dci_WX2N ? ?#pharma #regulatoryaffairs #whitepaper